Atypical acute motor axonal neuropathy following alemtuzumab treatment in multiple sclerosis patient

Acta Neurol Belg. 2017 Dec;117(4):965-967. doi: 10.1007/s13760-017-0799-2. Epub 2017 May 31.

Authors

Pavel Hradilek¹, I Woznicova², J Slonkova², A Lochmanova³, D Zeman²

Affiliations

¹ Department of Neurology, University Hospital Ostrava, 17. listopadu 1790, 708 52, Ostrava, Czech Republic. [email protected].
² Department of Neurology, University Hospital Ostrava, 17. listopadu 1790, 708 52, Ostrava, Czech Republic.
³ Department of Immunology and Allergology, Public Health Institute, Ostrava, Czech Republic.

PMID: 28567571
DOI: 10.1007/s13760-017-0799-2

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Alemtuzumab / adverse effects*
Antineoplastic Agents, Immunological / adverse effects*
Electromyography
Female
Humans
Magnetic Resonance Imaging
Multiple Sclerosis / diagnostic imaging
Multiple Sclerosis / drug therapy*
Neural Conduction / drug effects
Neural Conduction / physiology
Peripheral Nervous System Diseases / chemically induced*
Peripheral Nervous System Diseases / diagnostic imaging

Substances

Antineoplastic Agents, Immunological
Alemtuzumab